Tamoxifen cancer patients breast. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy11

Breast Cell Line, Tumor Tumor Cells, Cultured MCF-7 Cells Axilla Neoplastic Cells, Circulating Lymph Nodes Mammary Glands, Human Neoplastic Stem Cells Nipples Epithelial Cells

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases52

Breast Neoplasms Carcinoma, Ductal, Breast Neoplasms Breast Diseases Neoplasm Metastasis Lung Neoplasms Ovarian Neoplasms Neoplasm Invasiveness Prostatic Neoplasms Neoplasms, Hormone-Dependent Breast Neoplasms, Male Neoplasm Recurrence, Local Stomach Neoplasms Carcinoma Colonic Neoplasms Lymphatic Metastasis Colorectal Neoplasms Carcinoma, Lobular Endometrial Neoplasms Disease Progression Genetic Predisposition to Disease Adenocarcinoma Carcinoma, Intraductal, Noninfiltrating Pancreatic Neoplasms Mammary Neoplasms, Experimental Fibrocystic Breast Disease Carcinoma, Non-Small-Cell Lung Bone Neoplasms Uterine Cervical Neoplasms Neoplastic Cells, Circulating Neoplasms, Second Primary Carcinoma, Squamous Cell Rectal Neoplasms Urinary Bladder Neoplasms Head and Neck Neoplasms Carcinoma in Situ Cell Transformation, Neoplastic Carcinoma, Ductal Neovascularization, Pathologic Liver Neoplasms Esophageal Neoplasms Fatigue Gastrointestinal Neoplasms Genital Neoplasms, Female Neoplasms, Multiple Primary Mouth Neoplasms Fibroadenoma Carcinoma, Small Cell Precancerous Conditions Triple Negative Breast Neoplasms Melanoma Neoplasms, Radiation-Induced

Chemicals and Drugs59

Tamoxifen Antineoplastic Agents, Hormonal Estrogen Antagonists Receptors, Estrogen Selective Estrogen Receptor Modulators Tumor Markers, Biological Receptor, erbB-2 Aromatase Inhibitors Estrogen Receptor Modulators Antineoplastic Agents Nitriles Neoplasm Proteins Receptors, Progesterone Estrogen Receptor alpha Triazoles Estradiol Estrogens Fluorouracil Toremifene RNA, Messenger Raloxifene DNA, Neoplasm Cancer Vaccines Cytochrome P-450 CYP2D6 Antigens, Neoplasm Cyclophosphamide Anticarcinogenic Agents Antineoplastic Agents, Phytogenic Antibodies, Monoclonal Tumor Suppressor Protein p53 Epirubicin Cisplatin BRCA2 Protein BRCA1 Protein Antibodies, Monoclonal, Humanized Receptor, Epidermal Growth Factor Taxoids RNA, Small Interfering Ki-67 Antigen Mucin-1 RNA, Neoplasm Carcinoembryonic Antigen Aminoglutethimide Prostate-Specific Antigen Tumor Suppressor Proteins Paclitaxel Antimetabolites, Antineoplastic Methotrexate Deoxycytidine Estrogen Receptor beta Antibiotics, Antineoplastic MicroRNAs DNA Adducts DNA-Binding Proteins Transcription Factors Quinazolines Proto-Oncogene Proteins Proto-Oncogene Proteins c-akt Organoplatinum Compounds

Analytical, Diagnostic and Therapeutic Techniques and Equipment78

Prognosis Chemotherapy, Adjuvant Neoplasm Staging Survival Analysis Antineoplastic Combined Chemotherapy Protocols Disease-Free Survival Early Detection of Cancer Treatment Outcome Survival Rate Retrospective Studies Mastectomy Mammography Follow-Up Studies Risk Factors Prospective Studies Immunohistochemistry Reverse Transcriptase Polymerase Chain Reaction Gene Expression Profiling Risk Risk Assessment Multivariate Analysis Kaplan-Meier Estimate Sensitivity and Specificity Mammary Neoplasms, Experimental Combined Modality Therapy Case-Control Studies Mastectomy, Segmental Predictive Value of Tests Odds Ratio Breast Self-Examination Drug Administration Schedule Registries Blotting, Western Clinical Trials as Topic Neoplasm Transplantation Xenograft Model Antitumor Assays Incidence Cohort Studies Questionnaires Radiotherapy Reproducibility of Results Breast Implants Transplantation, Heterologous Polymerase Chain Reaction Radiotherapy, Adjuvant Oligonucleotide Array Sequence Analysis Tissue Array Analysis Neoplasm Grading Tumor Burden SEER Program Logistic Models Immunoenzyme Techniques Ultrasonography, Mammary Palliative Care Drug Screening Assays, Antitumor Lymph Node Excision Mammaplasty Neoadjuvant Therapy Confidence Intervals Proportional Hazards Models Biopsy, Needle Biopsy Transfection Pilot Projects Mastectomy, Modified Radical Sentinel Lymph Node Biopsy Radiotherapy Dosage Genetic Testing Molecular Targeted Therapy DNA Mutational Analysis In Situ Hybridization, Fluorescence Models, Biological Enzyme-Linked Immunosorbent Assay Ovariectomy Immunotherapy Double-Blind Method Analysis of Variance Feasibility Studies

Psychiatry and Psychology3

Breast Feeding Breast Self-Examination Smoking

Phenomena and Processes45

Gene Expression Regulation, Neoplastic Postmenopause Drug Resistance, Neoplasm Breast Feeding Premenopause Genetic Predisposition to Disease Genes, BRCA1 Risk Time Factors Menopause Sensitivity and Specificity Cell Proliferation Mutation Odds Ratio Dose-Response Relationship, Drug Genotype Cell Division Polymorphism, Genetic Genes, BRCA2 Apoptosis DNA Methylation Genes, erbB-2 Signal Transduction Germ-Line Mutation Down-Regulation Cell Movement Promoter Regions, Genetic Cell Cycle Up-Regulation Cell Growth Processes Transfection Genes, Neoplasm Gene Expression Genes, p53 Gene Amplification Phenotype RNA Interference Drug Synergism Cell Survival Base Sequence DNA Adducts Gene Silencing Genes, Tumor Suppressor Phosphorylation Alleles

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena2

Quality of Life National Cancer Institute (U.S.)

Humanities1

Quality of Life

Information Science7

Survival Rate Registries Incidence Questionnaires SEER Program Base Sequence Molecular Sequence Data

Named Groups2

Survivors European Continental Ancestry Group

Health Care34

Survival Analysis Disease-Free Survival Treatment Outcome Survival Rate Retrospective Studies Follow-Up Studies Risk Factors Prospective Studies Risk Risk Assessment Multivariate Analysis Age Factors Kaplan-Meier Estimate Sensitivity and Specificity Case-Control Studies Predictive Value of Tests Odds Ratio Registries Clinical Trials as Topic Incidence Cohort Studies Questionnaires Reproducibility of Results SEER Program Logistic Models Palliative Care National Cancer Institute (U.S.)Confidence Intervals Proportional Hazards Models Pilot Projects Genetic Testing Double-Blind Method Analysis of Variance Feasibility Studies

Geographicals3

United States Japan China

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Tamoxifen Breast Antineoplastic Agents, Hormonal Breast Neoplasms Estrogen Antagonists Receptors, Estrogen Carcinoma, Ductal, Breast Neoplasms Breast Diseases Selective Estrogen Receptor Modulators Prognosis Chemotherapy, Adjuvant Tumor Markers, Biological Neoplasm Staging Cell Line, Tumor Neoplasm Metastasis Receptor, erbB-2 Gene Expression Regulation, Neoplastic Lung Neoplasms Aromatase Inhibitors Estrogen Receptor Modulators Antineoplastic Agents Postmenopause Ovarian Neoplasms Survival Analysis Antineoplastic Combined Chemotherapy Protocols Neoplasm Invasiveness Drug Resistance, Neoplasm Disease-Free Survival Prostatic Neoplasms Early Detection of Cancer Neoplasms, Hormone-Dependent Breast Neoplasms, Male Treatment Outcome Neoplasm Recurrence, Local Nitriles Survival Rate Neoplasm Proteins Stomach Neoplasms Breast Feeding Receptors, Progesterone Retrospective Studies Mastectomy Mammography Follow-Up Studies Carcinoma Estrogen Receptor alpha Mice, Nude Triazoles Risk Factors Colonic Neoplasms Prospective Studies Estradiol Lymphatic Metastasis Colorectal Neoplasms Estrogens Fluorouracil Immunohistochemistry Toremifene Premenopause Carcinoma, Lobular Reverse Transcriptase Polymerase Chain Reaction Endometrial Neoplasms Disease Progression Genetic Predisposition to Disease Tumor Cells, Cultured Gene Expression Profiling Genes, BRCA1 Adenocarcinoma RNA, Messenger Carcinoma, Intraductal, Noninfiltrating Risk Risk Assessment Time Factors Raloxifene Multivariate Analysis Menopause Age Factors DNA, Neoplasm Kaplan-Meier Estimate Sensitivity and Specificity Pancreatic Neoplasms Cancer Vaccines Cell Proliferation Mammary Neoplasms, Experimental Combined Modality Therapy Case-Control Studies Fibrocystic Breast Disease Cytochrome P-450 CYP2D6 Mastectomy, Segmental Predictive Value of Tests Antigens, Neoplasm Mutation Quality of Life Survivors Odds Ratio Breast Self-Examination Carcinoma, Non-Small-Cell Lung Drug Administration Schedule MCF-7 Cells

No FAQ available that match "tamoxifen cancer patients breast"